AbCellera Biologics Inc (ABCL) has risen Thursday morning, with the stock adding 2.85% in pre-market trading to 5.05. ABCL's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 101 out of 146 industries, the stock ranks higher than 25% of stocks. AbCellera Biologics Inc has fallen 10.07% over the past month, closing at $5.28 on February 15. During this period of time, the stock fell as low as $4.77 and as high as $5.45. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $15.56.
ABCL has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on ABCL!